Apolipoprotein A-I Q[-2]X causing isolated apolipoprotein A-I deficiency in a family with analphalipoproteinemia.
Open Access
- 1 January 1994
- journal article
- case report
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 93 (1) , 223-229
- https://doi.org/10.1172/jci116949
Abstract
We report a Canadian kindred with a novel mutation in the apolipoprotein (apo) A-I gene causing analphalipoproteinemia. The 34-yr-old proband, product of a consanguineous marriage, had bilateral retinopathy, bilateral cataracts, spinocerebellar ataxia, and tendon xanthomata. High density lipoprotein cholesterol (HDL-C) was < 0.1 mM and apoA-I was undetectable. Genomic DNA sequencing of the proband's apoA-I gene identified a nonsense mutation at codon [-2], which we designate as Q[-2]X. This mutation causes a loss of endonuclease digestion sites for both BbvI and Fnu4HI. Genotyping identified four additional homozygotes, four heterozygotes, and two unaffected subjects among the first-degree relatives. Q[-2]X homozygosity causes a selective failure to produce any portion of mature apoA-I, resulting in very low plasma level of HDL. Heterozygosity results in approximately half-normal apoA-I and HDL. Gradient gel electrophoresis and differential electroimmunodiffusion assay revealed that the HDL particles of the homozygotes had peak Stokes diameter of 7.9 nm and contained apoA-II without apoA-I (Lp-AII). Heterozygotes had an additional fraction of HDL3-like particles. Two of the proband's affected sisters had documented premature coronary heart disease. This kindred, the third reported apoA-I gene mutation causing isolated complete apoA-I deficiency, appears to be at significantly increased risk for atherosclerosis.Keywords
This publication has 41 references indexed in Scilit:
- Characterization of apolipoprotein A-I- and A-II-containing lipoproteins in a new case of high density lipoprotein deficiency resembling Tangier disease and their effects on intracellular cholesterol efflux.Journal of Clinical Investigation, 1993
- Cholesterol transport between cells and high-density lipoproteinsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
- Lecithin-cholesterol acyltransferase (LCAT) deficiency with a missense mutation in exon 6 of the LCAT geneBiochemical and Biophysical Research Communications, 1991
- High-density lipoprotein inhibits the oxidative modification of low-density lipoproteinBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1990
- Relation of serum total cholesterol and high-density lipoprotein cholesterol percentage to the incidence of definite coronary events: Twenty-year follow-up of the donolo-Tel Aviv prospective coronary artery disease studyThe American Journal of Cardiology, 1987
- Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particlesBiochemical and Biophysical Research Communications, 1987
- Deficiency of apolipoproteins a-i and c-iii and severe coronary heart diseaseClinical Cardiology, 1986
- Familial Deficiency of Apolipoproteins A-I and C-III and Precocious Coronary-Artery DiseaseNew England Journal of Medicine, 1982
- Identification of lipoprotein families in a variant of human plasma apolipoprotein A deficiencyScandinavian Journal of Clinical and Laboratory Investigation, 1979
- CORNEAL OPACITY IN FAMILIAL PLASMA CHOLESTEROL ESTER DEFICIENCYActa Ophthalmologica, 1969